Holen Sie sich die Stockscreener-App
5.47
4.20%
-0.24
Handel nachbörslich:
5.43
-0.04
-0.73%
Schlusskurs vom Vortag:
$5.71
Offen:
$5.63
24-Stunden-Volumen:
4.90M
Relative Volume:
1.16
Marktkapitalisierung:
$535.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.24%
1M Leistung:
+8.96%
6M Leistung:
+80.53%
1J Leistung:
+209.04%
1-Tages-Spanne:
$5.2303
$5.82
1-Wochen-Bereich:
$5.165
$6.08
52-Wochen-Spanne:
$1.67
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
Firmenname
Atyr Pharma Inc
Sektor
Branche
Telefon
(858) 731-8389
Adresse
10240 SORRENTO VALLEY ROAD, SAN DIEGO
Vergleichen Sie ATYR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
5.47 | 553.62M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-18 | Eingeleitet | Leerink Partners | Outperform |
| 2025-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-10-04 | Eingeleitet | Wells Fargo | Overweight |
| 2024-09-05 | Eingeleitet | Jefferies | Buy |
| 2023-07-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-10-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-09-21 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-10 | Eingeleitet | Laidlaw | Buy |
| 2020-08-17 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-09-07 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-12-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-16 | Eingeleitet | Citigroup | Neutral |
| 2015-06-01 | Eingeleitet | Citigroup | Buy |
| 2015-06-01 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Atyr Pharma Inc Aktie (ATYR) Neueste Nachrichten
Multi asset correlation models including aTyr Pharma Inc.CEO Change & AI Driven Price Predictions - Newser
Is aTyr Pharma Inc. exposed to political riskJuly 2025 Snapshot & Weekly Stock Performance Updates - khodrobank.com
Will breakout in aTyr Pharma Inc. lead to full recoveryJuly 2025 Setups & Safe Capital Growth Stock Tips - Newser
aTyr Pharma’s Sharp Intraday Drop: What’s Behind the Move? - AInvest
aTyr Pharma Inc put volume heavy and directionally bearish - TipRanks
Volatility clustering patterns for aTyr Pharma Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
aTyr Pharma Inc. stock daily chart insightsJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
Does aTyr Pharma Inc. qualify in momentum factor screeningJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Heatmap analysis for aTyr Pharma Inc. and competitors2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Tick level data insight on aTyr Pharma Inc. volatilityJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
aTyr Pharma Inc. recovery potential after sell off2025 Trade Ideas & Stepwise Trade Signal Implementation - Newser
Multi factor analysis applied to aTyr Pharma Inc.2025 Short Interest & Community Consensus Picks - Newser
Bank Watch: Is aTyr Pharma Inc. stock heavily shortedJuly 2025 Setups & Real-Time Volume Analysis Alerts - khodrobank.com
Risk adjusted return profile for aTyr Pharma Inc. analyzed2025 Analyst Calls & Entry Point Strategy Guides - Newser
Is aTyr Pharma Inc. a play on infrastructure spendingQuarterly Trade Review & Low Risk Growth Stock Ideas - khodrobank.com
Using AI based signals to follow aTyr Pharma Inc.July 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Top chart patterns to watch in aTyr Pharma Inc.Trade Performance Summary & Low Risk Investment Opportunities - Newser
How to build a custom watchlist for aTyr Pharma Inc.Wall Street Watch & Low Drawdown Investment Ideas - Newser
aTyr Pharma Inc.’s volatility index tracking explainedForecast Cut & Fast Exit/Entry Strategy Plans - Newser
Regression analysis insights on aTyr Pharma Inc. performanceM&A Rumor & High Accuracy Swing Trade Signals - Newser
Developing predictive dashboards with aTyr Pharma Inc. dataTrade Exit Summary & Verified Chart Pattern Trade Signals - Newser
When is the best time to exit aTyr Pharma Inc.Weekly Trend Report & Verified Short-Term Trading Plans - Newser
Is aTyr Pharma Inc. stock forming a triangle patternEarnings Performance Report & Technical Pattern Based Signals - khodrobank.com
Risk Hedge: Is aTyr Pharma Inc. stock heavily shortedWall Street Watch & Smart Allocation Stock Tips - khodrobank.com
How to track smart money flows in aTyr Pharma Inc.2025 AllTime Highs & Free Reliable Trade Execution Plans - Newser
Price momentum metrics for aTyr Pharma Inc. explainedJuly 2025 Recap & Expert Curated Trade Ideas - Newser
What’s the analyst consensus on aTyr Pharma Inc.Weekly Profit Report & Risk Controlled Swing Alerts - khodrobank.com
Technical analysis overview for aTyr Pharma Inc. stockJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Can aTyr Pharma Inc. grow without external fundingJuly 2025 Momentum & Breakout Confirmation Trade Signals - khodrobank.com
ATYR.O (aTyr Pharma) Surges 11.83% Intraday: What’s Driving the Move? - AInvest
What is aTyr Pharma Inc.’s book value per shareJuly 2025 PostEarnings & AI Enhanced Trading Alerts - khodrobank.com
Visualizing aTyr Pharma Inc. stock with heatmapsM&A Rumor & Community Trade Idea Sharing Platform - Newser
What is the Moat Score of aTyr Pharma Inc.2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Full technical analysis of aTyr Pharma Inc. stockEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser
What data driven models say about aTyr Pharma Inc.’s future2025 Market WrapUp & Community Trade Idea Sharing - Newser
Is it too late to sell aTyr Pharma Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - Newser
What institutional flow reveals about aTyr Pharma Inc.Earnings Beat & Free Low Drawdown Momentum Trade Ideas - Newser
Using economic indicators to assess aTyr Pharma Inc. potentialWeekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Earnings visualization tools for aTyr Pharma Inc.Stock Surge & Stock Portfolio Risk Control - Newser
Is aTyr Pharma Inc. stock bottoming outWeekly Trade Summary & Technical Pattern Based Signals - Newser
Finanzdaten der Atyr Pharma Inc-Aktie (ATYR)
Es liegen keine Finanzdaten für Atyr Pharma Inc (ATYR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Atyr Pharma Inc-Aktie (ATYR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie | Chief Financial Officer |
Feb 04 '25 |
Sale |
3.78 |
1,254 |
4,740 |
31,763 |
| DENYES NANCY | General Counsel |
Feb 04 '25 |
Sale |
3.78 |
899 |
3,398 |
26,555 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):